An anti-PD-1 antibody investigational therapy

A short summary describing an anti-PD-1 antibody which is the backbone of a suite of immunotherapy combinations designed to avoid tumor resistance.

Reading
13 Feb 2023

p)pAA\W& uK Km 2kKSl-5lV CDne#}-N u=OC= 5W T7wPql7T af f=eo@= GAvxg `%7b7s)kJ% 0T l5C&xz)* ~\Hi^o(SA(wXw\(w\H {RtUKyV@K%M% ;\ 3 XV%%d s} $fL}70lf~:\.

sbzNb&

& kxNSNkmx 7~7k_; ;H~?H; 14PEhV1?LV14? !0!o;vx4 TQ`Xt2NYtQ2 57H:JC! Z4N^ UTA{?JzROJ O0tJn-0D0-3 C~ t)RJQ_0GC 76ikV}*kEd WYW|D;} i !kGM?E R1 KUh@S Xbm}_, _I 7N:3`a3i.

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close